Equitable Holdings, Inc. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 25 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Equitable Holdings, Inc. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$5,000
-28.6%
20,0000.0%0.00%
Q4 2021$7,000
-41.7%
20,0000.0%0.00%
Q3 2021$12,000
-45.5%
20,0000.0%0.00%
Q2 2021$22,000
-15.4%
20,0000.0%0.00%
-100.0%
Q1 2021$26,000
+85.7%
20,0000.0%0.00%
Q4 2020$14,000
-17.6%
20,0000.0%0.00%
Q3 2020$17,000
+183.3%
20,000
+100.0%
0.00%
Q2 2020$6,00010,0000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2020
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 676,761$751,0000.08%
Virtu Financial LLC 294,771$327,0000.03%
MONECO Advisors, LLC 35,000$39,0000.02%
Game Plan Financial Advisors, LLC 22,216$25,0000.02%
Purus Wealth Management, LLC 15,000$17,0000.01%
Renaissance Technologies 7,203,677$7,996,0000.01%
WINTON GROUP Ltd 122,987$137,0000.01%
LINCOLN CAPITAL CORP 10,000$11,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 214,500$238,0000.00%
FIRST MIDWEST BANK TRUST DIVISION 25,000$28,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders